Overexpression of Ad5 precursor terminal protein accelerates recombinant adenovirus packaging and amplification in HEK-293 packaging cells

Gene Therapy

Volumn 21, Issue 7, 2014, Pages 629-637

  Wu, N ^a,b,c   Zhang, H ^b,c   Deng, F ^b,d   Li, R ^b,c   Zhang, W ^b,e   Chen, X ^b,c   Wen, S ^a,b   Wang, N ^b,d   Zhang, J ^b,c   Yin, L ^b,c   Liao, Z ^b,f   Zhang, Z ^b,g   Zhang, Q ^a,b   Yan, Z ^b,c   Liu, W ^a,b   Wu, D ^b   Ye, J ^b,h   Deng, Y ^b,c   Yang, K ^a,b   Luu, H H ^b   Haydon, R C ^b   He, T C ^a,b,c   more..

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e Department of Laboratory Medicine Affiliated Hospital of Bingzhou Medical University   (China)

^f CENTRAL SOUTH UNIVERSITY   (China)

^g ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^h CHONGQING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 6; GREEN FLUORESCENT PROTEIN; LUCIFERASE; PRECURSOR TERMINAL PROTEIN; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; PHOSPHOPROTEIN; PTP PROTEIN, ADENOVIRUS; VIRUS PROTEIN;

ARTICLE; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; GENE EXPRESSION SYSTEM; GENE OVEREXPRESSION; GENETIC ENGINEERING; HEK293 CELL LINE; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; IMMORTALIZED CELL LINE; PRIORITY JOURNAL; TRANSPOSON; ADENOVIRIDAE; ADENOVIRUS INFECTION; ANIMAL; ANIMAL EMBRYO; CYTOLOGY; FIBROBLAST; GENE VECTOR; GENETIC RECOMBINATION; GENETIC TRANSDUCTION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY; VIRUS ASSEMBLY;

ADENOVIRIDAE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; CELL LINE, TUMOR; EMBRYO, MAMMALIAN; FIBROBLASTS; GENETIC VECTORS; HEK293 CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; PHOSPHOPROTEINS; PROTEIN PRECURSORS; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC; VIRAL PROTEINS; VIRUS ASSEMBLY;

EID: 84903879742     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2014.40     Document Type: Article

References (50)

1. Breyer B, Jiang W, Cheng H, Zhou L, Paul R, Feng T, et al. Adenoviral vectormediated gene transfer for human gene therapy. Curr Gene Ther 2001; 1: 149-162
2. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40
3. Lou J, Xu F, Merkel K, Manske P. Gene therapy: Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 1999; 17: 43-50
4. St George JA. Gene therapy progress and prospects: Adenoviral vectors. Gene Ther 2003; 10: 1135-1141
5. Kay MA. State-of-The-Art gene-based therapies: The road ahead. Nat Rev Genet 2011; 12: 316-328
6. Ketner G, Spencer F, Tugendreich S, Connelly C, Hieter P. Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone. Proc Nati Acad Sci USA 1994; 9: 6186-6190
7. Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996; 70: 4805-4810
8. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514
9. Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2007; 2: 1236-1247
10. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. Construction of adenovirus vectors through Cre-lox recombination. J Virol 1997; 7: 1842-1849
11. Ng P, Parks RJ, Cummings DT, Evelegh CM, Sankar U, Graham FL. A high-efficiency Cre/loxP-based system for construction of adenoviral vectors. Hum Gene Ther 1999; 10: 2667-2672
12. Stillman BW. The replication of adenovirus DNA with purified proteins. Cell 1983; 35: 7-9
13. Liu H, Naismith JH, Hay RT. Adenovirus DNA replication. Curr Top Microbiol Immunol 2003; 272: 131-164
14. Lichy JH, Field J, Horwitz MS, Hurwitz J. Separation of the adenovirus terminal protein precursor from its associated DNA polymerase: Role of both proteins in the initiation of adenovirus DNA replication. Proc Natl Acad Sci USA 1982; 79: 5225-5229
15. de Jong RN, van der Vliet PC. Mechanism of DNA replication in eukaryotic cells: Cellular host factors stimulating adenovirus DNA replication. Gene 1999; 236: 1-12
16. Schaack J, Ho WY, Freimuth P, Shenk T. Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA. Genes Dev 1990; 4: 1197-1208
17. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-74
18. Luther GA, Lamplot J, Chen X, Rames R, Wagner ER, Liu X, et al. IGFBP5 Domains Exert Distinct Inhibitory Effects on the Tumorigenicity and Metastasis of Human Osteosarcoma. Cancer Lett 2013; 336: 222-230
19. Huang E, Bi Y, Jiang W, Luo X, Yang K, Gao JL, et al. Conditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential. PLoS One 2012; 7: E32428
20. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85-A: 1544-1552
21. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004; 1: 1312-1320
22. Luu HH, Song WX, Luo X, Manning D, Luo J, Deng ZL, et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 2007; 25: 665-677
23. Schaack J, Guo X, Ho WY, Karlok M, Chen C, Ornelles D. Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines. J Virol 1995; 69: 4079-4085
24. Langer SJ, Schaack J 293 cell lines that inducibly express high levels of adenovirus type 5 precursor terminal protein. Virology 1996; 221: 172-179
25. Amalfitano A, Chamberlain JS. Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: Implications for gene therapy. Gene Ther 1997; 4: 258-263
26. Lieber A, He CY, Kay MA. Adenoviral preterminal protein stabilizes mini-Adenoviral genomes in vitro and in vivo. Nat Biotechnol 1997; 15: 1383-1387
27. Hoeben RC, Uil TG. Adenovirus DNA replication. Cold Spring Harb Perspect Biol 2013; 5: A013003
28. Mysiak ME, Wyman C, Holthuizen PE, van der Vliet PC. NFI and Oct-1 bend the Ad5 origin in the same direction leading to optimal DNA replication. Nucleic Acids Res 2004; 32: 6218-6225
29. Gao Y, Huang E, Zhang H, Wang J, Wu N, Chen X, et al. Crosstalk between Wnt/beta-catenin and estrogen receptor signaling synergistically promotes osteogenic differentiation of mesenchymal progenitor cells. PLoS One 2013; 8: E82436
30. Kong Y, Zhang H, Chen X, Zhang W, Zhao C, Wang N, et al. Destabilization of heterologous proteins mediated by the GSK3beta phosphorylation domain of the beta-catenin protein. Cell Physiol Biochem 2013; 32: 1187-1199
31. Zhang W, Zhang H, Wang N, Zhao C, Zhang H, Deng F, et al. Modulation of beta-Catenin Signaling by the Inhibitors of MAP Kinase, Tyrosine Kinase, and PI3-Kinase Pathways. Int J Med Sci 2013; 10: 1888-1898
32. Chen X, Luther G, Zhang W, Nan G, Wagner ER, Liao Z, et al. The E-F hand calcium-binding protein s100a4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells. Cell Physiol Biochem 2013; 32: 1083-1096
33. Kang Q, Song WX, Luo Q, Tang N, Luo J, Luo X, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009; 18: 545-559
34. Huang J, Bi Y, Zhu GH, He Y, Su Y, He BC, et al. Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int 2009; 29: 1569-1581
35. Zhang W, Deng ZL, Chen L, Zuo GW, Luo Q, Shi Q, et al. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One 2010; 5: E11917
36. Zhu GH, Huang J, Bi Y, Su Y, Tang Y, He BC, et al. Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation 2009; 78: 195-204
37. Rastegar F, Gao JL, Shenaq D, Luo Q, Shi Q, Kim SH, et al. Lysophosphatidic acid acyltransferase beta (LPAATbeta) promotes the tumor growth of human osteosarcoma. PLoS One 2010; 5: E14182
38. Su Y, Wagner ER, Luo Q, Huang J, Chen L, He BC, et al. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 2011; 30: 3907-3917
39. Peng Y, Kang Q, Luo Q, Jiang W, Si W, Liu BA, et al. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004; 279: 32941-32949
40. Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, et al. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 2003; 90: 1149-1165
41. Sharff KA, Song WX, Luo X, Tang N, Luo J, Chen J, et al. Hey1 basic helix-loop-helix protein plays an important role in mediating bmp9-induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem 2009; 284: 649-659
42. Liu X, Qin J, Luo Q, Bi Y, Zhu G, Jiang W, et al. Cross-Talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells. J Cell Mol Med 2013; 17: 1160-1172
43. Zhang J, Weng Y, Liu X, Wang J, Zhang W, Kim SH, et al. Endoplasmic reticulum (ER) stress inducible factor cysteine-rich with EGF-like domains 2 (Creld2) is an important mediator of BMP9-regulated osteogenic differentiation of mesenchymal stem cells. PLoS One 2013; 8: E73086
44. Luo X, Chen J, Song WX, Tang N, Luo J, Deng ZL, et al. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 2008; 88: 1264-1277
45. Luo Q, Kang Q, Si W, Jiang W, Park JK, Peng Y, et al. Connective tissue growth factor (CTGF) Is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004; 279: 55958-55968
46. Tang N, Song WX, Luo J, Luo X, Chen J, Sharff KA, et al. BMP9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/ beta-catenin signaling. J Cell Mol Med 2009; 13: 2448-2464
47. Chen L, Jiang W, Huang J, He BC, Zuo GW, Zhang W, et al. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res 2010; 25: 2447-2459
48. Bi Y, Huang J, He Y, Zhu GH, Su Y, He BC, et al. Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. J Cell Biochem2009; 108: 295-303
49. Yang K, Chen J, Jiang W, Huang E, Cui J, Kim SH, et al. Conditional immortalization establishes a repertoire of mouse melanocyte progenitors with distinct melanogenic differentiation potential. J Invest Dermatol 2012; 132: 2479-2483
50. Wang X, Cui J, Zhang BQ, Zhang H, Bi Y, Kang Q, et al. Decellularized liver scaffolds effectively support the proliferation and differentiation of mouse fetal hepatic progenitors. J Biomed Mater Res 2013; 102: 1017-1025.